KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

AbbVie (ABBV) Interest & Investment Income (2016 - 2025)

AbbVie (ABBV) has disclosed Interest & Investment Income for 14 consecutive years, with -$655.0 million as the latest value for Q4 2025.

  • On a quarterly basis, Interest & Investment Income fell 7.38% to -$655.0 million in Q4 2025 year-over-year; TTM through Dec 2025 was -$2.6 billion, a 21.62% decrease, with the full-year FY2025 number at -$2.6 billion, down 21.62% from a year prior.
  • Interest & Investment Income was -$655.0 million for Q4 2025 at AbbVie, up from -$667.0 million in the prior quarter.
  • In the past five years, Interest & Investment Income ranged from a high of -$378.0 million in Q4 2023 to a low of -$678.0 million in Q2 2025.
  • A 5-year average of -$544.9 million and a median of -$555.0 million in 2021 define the central range for Interest & Investment Income.
  • Peak YoY movement for Interest & Investment Income: grew 20.59% in 2023, then tumbled 61.38% in 2024.
  • AbbVie's Interest & Investment Income stood at -$571.0 million in 2021, then grew by 16.64% to -$476.0 million in 2022, then increased by 20.59% to -$378.0 million in 2023, then crashed by 61.38% to -$610.0 million in 2024, then fell by 7.38% to -$655.0 million in 2025.
  • Per Business Quant, the three most recent readings for ABBV's Interest & Investment Income are -$655.0 million (Q4 2025), -$667.0 million (Q3 2025), and -$678.0 million (Q2 2025).